Management and treatment strategy of patients with DKD includes controlling blood glucose, blood lipid, and blood pressure as well as blockade of the renin-angiotensin system (RAS); however, the risk of DKD still remains to be high (3) indicating the presence of unrecognized factors and mechanisms involved. The gene discussed is REN; the disease is diabetic kidney disease.